Income Statement
GLOBAL MEDICAL REIT INC.
XRN
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Aug 31, 2013 2013 FY | Aug 31, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
148.21 | 138.78 | 141.05 | 137.28 | 115.94 | 93.73 | 70.73 | 53.19 | 30.34 | 8.21 | 2.06 | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
148.21 | 138.78 | 141.05 | 137.28 | 115.94 | 93.73 | 70.73 | 53.19 | 30.34 | 8.21 | 2.06 | - | - |
|
Operating Expenses
|
20.00 | 21.12 | 134.01 | 124.04 | 98.66 | 96.23 | 61.14 | 46.31 | 30.43 | 14.56 | 3.67 | 0.05 | 0.05 |
|
Research & Development
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Selling, General & Administrative
|
20.00 | 21.12 | 16.85 | 16.55 | 16.45 | 11.94 | 6.54 | 5.54 | 5.49 | 4.29 | 0.51 | 0.05 | 0.05 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
128.21 | 117.66 | 7.04 | 13.24 | 17.27 | -2.50 | 9.59 | 6.89 | -0.09 | -6.35 | -1.61 | -0.05 | -0.05 |
|
Non-Operating Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
28.19 | 0.82 | 30.89 | 25.23 | 19.70 | 18.68 | 17.47 | 14.98 | 7.44 | 4.14 | 1.52 | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
-1.05 | 0.06 | 1.12 | 0.85 | 0.72 | -0.57 | 0.35 | 1.07 | -0.05 | - | - | - | - |
|
Net Income
|
0.00 | 6.69 | 21.73 | 20.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -6.35 | -1.61 | -0.05 | -0.05 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Aug 31, 2013 2013 FY | Aug 31, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
128.21 | 117.66 | 7.04 | 13.24 | 17.27 | -2.50 | 9.59 | 6.89 | -0.09 | -6.35 | -0.95 | -0.05 | -0.05 |
|
Earnings Per Share (Basic)
|
-0.91 | 0.01 | 0.23 | 0.20 | 0.19 | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.91 | 0.01 | 0.23 | 0.20 | 0.19 | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
13.38 | 65.94 | 65.55 | 65.46 | 60.64 | - | - | - | - | - | - | - | 5.50 |
|
Diluted Weighted Avg Shares
|
13.38 | 65.94 | 65.55 | 65.46 | 60.64 | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | 29.93 | -14.04 | 6.64 | 10.84 | - | - | - | - | - |